AIDS Therapies

ViroLogic Awarded Grant For HIV Drug Resistance Testing

Published in AIDS Weekly, October 1st, 2001

ViroLogic, Inc. has been exclusively awarded a $1.2 million Ryan White CARE Grant for HIV drug resistance testing in Washington, DC.

The grant will provide testing access to low-income individuals in the D.C. metropolitan area who have HIV disease and limited or no health coverage from private insurance or Medicaid.

The Ryan White CARE Grant will allow ViroLogic to provide HIV drug resistance testing for thousands of people living in the Washington, DC, area who have HIV disease. Testing for qualified recipients will be paid 100% through these funds, and the grant is effective through February 2002.

Residents of that area...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-10-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry